COMP <GO>
JANX vs HROW // GROSS PROFIT MARGIN
Janux Therapeutics Inc. (NASDAQ) VS. Harrow Inc. (NASDAQ) • 15-METRIC TALLY: JANX 2
— HROW 3
■ METRIC PARITY
LAST: $17.46 (-0.06%) • MKT CAP: $1.07B
gross-margins
—
LAST: $28.20 (-0.14%) • MKT CAP: $1.06B
gross-margins
75.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JANX VS. HROW)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JANX | HROW | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 75.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.80% | 42.90% | -56.70 | HROW | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.64% | 3.82% | -11.46 | HROW | /fcf-yield <GO> |
| Operating Margin | — | 11.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -1.90% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 36.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.67 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | HROW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.4 | 41.5 | +9.90 | JANX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.07B | $1.06B | $9.4M | JANX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JANX REV | HROW REV | JANX GROSS % | HROW GROSS % | JANX FCF | HROW FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $441.5M | $272.3M | — | 75.1% | -$83.3M | $43.0M |
| FY 2024 | $276.8M | $199.6M | — | 75.3% | -$44.2M | -$23.8M |
| FY 2023 | $204.3M | $130.2M | — | — | -$50.6M | $3.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JANX // BETA —
HROW // BETA —